Colossal Biosciences, the Dallas-based biotechnology company known for its bold mission to resurrect extinct species such as the woolly mammoth and the dodo, announced its first-ever acquisition today: ViaGen Pets & Equine, a Texas company specializing in animal cloning and genetic preservation.
The deal, confirmed by Business Wire and The Austin American-Statesman, marks a major expansion of Colossal's technical and commercial capabilities. ViaGen, which has operated for more than two decades in the animal cloning industry, will continue to operate as a subsidiary under its existing leadership.
